Puma Biotechnology(PBYI)
$7.34-0.43 (-5.53%)
PBYI
Puma Biotechnology ownership
$7.34
At close:-0.43 (-5.53%)
Want to see PBYI full AI Analyst Report?
Puma Biotechnology (PBYI) Ownership - Who Owns Puma Biotechnology?
680 Followers
Puma Biotechnology (PBYI) Ownership Overview
- 15.78% Insiders
- 16.21% Mutual Funds
- 17.52% Other Institutional Investors
- 18.33% ETFs
- 32.16% Public Companies and Individual Investors
The ownership structure of Puma Biotechnology (PBYI) stock is a mix of institutional, retail, and individual investors. Approximately 52.06% of the company’s stock is owned by Institutional Investors, 15.78% is owned by Insiders, and 32.16% is owned by Public Companies and Individual Investors.
The ownership structure of Puma Biotechnology (PBYI) stock is a mix of institutional, retail, and individual investors. Approximately 52.06% of the company’s stock is owned by Institutional Investors, 15.78% is owned by Insiders, and 32.16% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 12, 2026 | Michael Patrick Miller | $121,350 | |
| Nov 12, 2025 | Michael Patrick Miller | $97,200 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Royce & Associates Llc | $133,787 | |
| Sep 30, 2026 | Entrypoint Capital, Llc | $345,127 | |
| Sep 30, 2026 | $41,777,307 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Alan Auerbach | 7,261,671 | Insider | 14.05% | 56,423,184 |
| BlackRock, Inc. | 4,207,181 | Institution | 8.14% | 32,689,796 |
| Avantis | 2,825,128 | Institution | 5.46% | 21,951,245 |
| Vanguard | 2,240,536 | Institution | 4.33% | 17,408,965 |
| Ishares | 1,862,763 | Institution | 3.60% | 14,473,669 |
| Vanguard Index Funds | 1,780,862 | Institution | 3.44% | 13,837,298 |
| Dfa | 860,565 | Institution | 1.66% | 6,686,590 |
| Vanguard Explorer Fund | 777,390 | Institution | 1.50% | 6,040,320 |
| Dfa Investment Dimensions Group Inc | 771,194 | Institution | 1.49% | 5,992,177 |
| Vanguard Horizon Funds | 607,581 | Institution | 1.18% | 4,720,904 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,780,862 | Institution | 3.44% | 13,837,298 |
| Vanguard Explorer Fund | 777,390 | Institution | 1.50% | 6,040,320 |
| Dfa Investment Dimensions Group Inc | 771,194 | Institution | 1.49% | 5,992,177 |
| Vanguard Horizon Funds | 607,581 | Institution | 1.18% | 4,720,904 |
| Bridgeway Funds, Inc. | 563,500 | Institution | 1.09% | 4,378,395 |
| Fidelity Salem Street Trust | 548,536 | Institution | 1.06% | 4,262,125 |
| Fidelity Concord Street Trust | 357,273 | Institution | 0.69% | 2,776,011 |
| Vanguard Scottsdale Funds | 300,086 | Institution | 0.58% | 2,331,668 |
| Russell Investment Co | 248,058 | Institution | 0.48% | 1,927,411 |
| Blackrock Funds | 206,044 | Institution | 0.40% | 1,600,962 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Avantis U.S. Small Cap Value ETF, AVUV ETF | 2,556,827 | Institution | 4.95% | 20,659,162 |
| Vanguard Total Stock Market ETF, VTI ETF | 1,343,121 | Institution | 2.60% | 13,337,192 |
| iShares Russell 2000 ETF, IWM ETF | 1,177,767 | Institution | 2.28% | 9,151,250 |
| Vanguard Extended Market ETF, VXF ETF | 460,043 | Institution | 0.89% | 4,568,227 |
| Dimensional U.S. Targeted Value ETF, DFAT ETF | 384,736 | Institution | 0.74% | 3,108,667 |
| Dimensional U.S. Small Cap ETF, DFAS ETF | 380,741 | Institution | 0.74% | 3,076,387 |
| iShares Russell 2000 Value ETF, IWN ETF | 359,363 | Institution | 0.70% | 2,792,251 |
| Vanguard Russell 2000 ETF, VTWO ETF | 257,267 | Institution | 0.50% | 2,554,661 |
| EA Bridgeway Omni Small-Cap Value ETF, BSVO ETF | 248,990 | Institution | 0.48% | 2,011,839 |
| Fidelity Enhanced Small Cap ETF, FESM ETF | 223,373 | Institution | 0.43% | 1,735,608 |
FAQ
Who Owns Puma Biotechnology (PBYI)?
According to the latest TipRanks data, approximately 52.06% of the company's stock is held by institutional investors, 15.78% is held by insiders, and 32.16% is held by public companies and individual investors.
What percentage of Puma Biotechnology (PBYI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 52.06% of Puma Biotechnology (PBYI) stock is held by institutional investors: 16.21% by mutual funds, 18.33% by ETFs and 17.52% by other institutional investors.
What percentage of Puma Biotechnology (PBYI) stock is held by retail investors?
According to the latest TipRanks data, approximately 32.16% of Puma Biotechnology (PBYI) stock is held by public companies and individual investors.
Who owns the most shares of Puma Biotechnology (PBYI)?
Alan Auerbach owns the most shares of Puma Biotechnology (PBYI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

